Two families of synthetic peptides that enhance fibrin turbidity and delay fibrinolysis by different mechanisms

Biochemistry

Volumn 48, Issue 30, 2009, Pages 7201-7208

  Pandi, Leela ^a   Kollman, Justin M ^a,b   Lopez Lira, Francisco ^a,c   Burrows, Jason M ^a   Riley, Marcia ^a   Doolittle, Russell F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Genomic Medicine Laboratory   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

C-DOMAIN; CLOT TURBIDITY; DIFFERENT MECHANISMS; FIBRIN CLOTS; IN-VITRO; PENTAPEPTIDES; POSITIVELY CHARGED PEPTIDES; SYNTHETIC PEPTIDE;

AMINO ACIDS; GELATION; PEPTIDES;

TURBIDITY;

FIBRIN; FIBRINOGEN; PEPTIDE; TRANEXAMIC ACID;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DIMERIZATION; FIBRINOLYSIS; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN BINDING; PROTEIN CONFORMATION; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; CRYSTALLOGRAPHY, X-RAY; DIMERIZATION; FIBRIN; FIBRINOGEN; FIBRINOLYSIS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; TRANEXAMIC ACID;

EID: 70350722262     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi900647g     Document Type: Article

References (36)

1. Laudano, A. P., and Doolittle, R. F. (1978) Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. Proc. Natl. Acad. Sci. U.S.A. 75, 3085-3089. (Pubitemid 8395123)
2. Doolittle, R. F., and Pandi, L. (2006) Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin. Biochemistry 45, 2657-2667.
3. Doolittle, R. F., and Pandi, L. (2007) Probing the β-chain holes of fibrinogen with synthetic peptides that differ at their amino termini. Biochemistry 46, 10033-10038. (Pubitemid 47378594)
4. Demple, C.-E., Bindeballe, N., Munchback, M., Blume, C., Borggrefe, M., and Mosesson, M. W. (2007) Changes in fibrinogen and fibrin induced by a peptide analog of fibrinogen γ365-380. J. Thromb. Haemostasis 5, 1707-1714. (Pubitemid 47091415)
5. Doolittle, R. F. (2008) Searching for Differences Between Fibrinogen and Fibrin That Affect the Initiation of Fibrinolysis. Cardiovasc. Hematol. Agents Med. Chem. 6, 181-189.
6. 1 in the γC-domain of fibrinogen. J. Biol. Chem. 278, 32251-32528.
7. 3 (glycoprotein IIb/IIIa). Biochemistry 44, 16290-16930.
8. Marx, G., Ben-Moshe, M., Magdassi, S., and Gorodetsky, R. (2004) Fibrinogen C-terminal peptide sequences (Haptides) modulate fibrin polymerization. Thromb. Haemostasis 91, 43-51. (Pubitemid 38111219)
9. Gebhardt, K., Lauvrak, V., Babaie, E., Eijsink, V., and Lindquist, B. H. (1996) Pept. Res. 9, 269-278.
10. Doolittle, R. F., Schubert, D., and Schwartz, S. A. (1967) Amino acid sequence studies on artiodactyls fibrinopeptides. I. Dromedary camel, mule deer and Cape Buffalo. Arch. Biochem. Biophys. 118, 456-467.
11. Finlayson, J. S., and Mosesson, M. W. (1963) Heterogeneity of human fibrinogen. Biochemistry 2, 42-46.
12. Mosesson, M. W., Finlayson, J. S., Umfleet, R. A., and Galanakis, D. (1972) Human fibrinogen heterogeneities. I. Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates. J. Biol. Chem. 247, 5210-5219.
13. Spraggon, G., Everse, S. J., and Doolittle, R. F. (1997) Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature 389, 455-462. (Pubitemid 27435313)
14. Deutsch, D. G., and Mertz, E. T. (1970) Plasminogen: Purification from human plasma by affinity chromatography. Science 170, 1095-1096.
15. Carr, M. E., and Herman, J. (1978) Size and density of fibrin fibers from turbidity. Macromolecules 11, 46-50.
16. Camerini-Otero, R. D., and Day, L. A. (1978) The wavelength dependence of turbidity of solutions of macromolecules. Biopolymers 17, 2241-2249. (Pubitemid 9015233)
17. Carr, M. E., and Gabriel, D. A. (1980) Dextran-induced changes in fibrin fiber size and density based on wavelength dependence of gel turbidity. Macromolecules 13, 1473-1477.
18. Weisel, J. W., and Nagaswami, C. (1992)Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: Clot structure and assembly are kinetically controlled. Biophys. J. 63, 111-128.
19. Otwinowski, Z., and Minor, W. (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326. (Pubitemid 27085611)
20. Navaza, J. (2001) Implementation of molecular replacement in AmoRe. Acta Crystallogr. D57, 1367-1372.
21. CollaborativeComputational Project Number 4 (1994) . Acta Crystallogr. D50, 760-763.
22. Jones, T. A., Zou, J. Y., Cowan, S. W., and Kjeldgaard, M. (1991) Improved methods for building proteins in electron density maps and the location of errors in these models. Acta Crystallogr. A47, 110-119.
23. Brunger, A. T., Adams, P. D., Chlore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J.-S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Crystallography andNMRsystem:A new software suite for macromolecular structure determination. Acta Crystallogr. D54, 905-921.
24. Strong, M., Sawaya, M. R., Wang, S., Phillips, M., Cascio, D., and Eisenberg, D. (2006) Toward a structural genomics of complexes: Crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 103, 8060-8065. (Pubitemid 43801052)
25. Laskowski, R. A., MacArthur, M. W., Moss, D. S., and Thornton, J. M. (1993) PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283-291.
26. Delano, W. L. (2002) The PyMOL Molecular Graphics System, DeLano Scientific, San Carlos, CA.
27. Iwamoto, M. (1975) Plasminogen-plasmin system IX. Specific binding of tranexamic acid to plasmin. Thromb. Diath. Haemorrh. 33, 573-585.
28. Markus, G., Priore, R. L., and Wissler, F. C. (1979) The binding of tranexamic acid to native (Glu) and modified (Lys) human plasminogen and its effect on conformation. J. Biol. Chem. 254, 1211-1216.
29. Everse, S. J., Spraggon, G., Veerapandian, L., and Doolittle, R. F. (1999) Conformational changes in fragments D and double-D from human fibrin(ogen) upon binding the peptide ligand Gly-His-Arg-Pro-amide. Biochemistry 38, 2941-2946.
30. Ferry, J. D., and Morrison, P. R. (1947) The conversion of human fibrinogen to fibrin under various conditions. J. Am. Chem. Soc. 69, 388-400.
31. Gabriel, D. A., Muga, K., and Boothroyd, E. M. (1992) The effect of fibrin structure on fibrinolysis. J. Biol. Chem. 267, 24259-24263.
32. Carr, M., and Alving, B. M. (1995) Effect of fibrin structure on plasmin-mediated dissolution of plasma clots. Blood Coagulation Fibrinolysis 6, 567-573.
33. Kim, P. Y., Stewart, R. J., Lipson, S. M., and Nesheim, M. E. (2007) The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease. J. Thromb. Haemostasis 5, 1250-1256. (Pubitemid 46902128)
34. Collet, J.-P., Lesty, C., Montalescot, G., and Weisel, J. W. (2003) Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots. J. Biol. Chem. 278, 21331-21335. (Pubitemid 36792527)
35. Yang, Z., Mochalkin, I., and Doolittle, R. F. (2000) A model of fibrin formation based on crystal structures of fibrinogen and fibrin complexed with synthetic peptides. Proc. Natl. Acad. Sci. U.S.A. 97, 14156-14161. (Pubitemid 32016546)
36. Kollman, J. M., Pandi, L., Sawaya, M. R., Riley, M., and Doolittle, R. F. (2009) Crystal structure of human fibrinogen. Biochemistry 48, 3877-3886.